Myeloma Institute for Research and Therapy
Home
What is Myeloma?
About the Institute
Referring or
Becoming a Patient
Our Doctors and Staff
  Our Doctor Team
  Our Nursing Team and Other Health Professionals
UAMS
News/Events/Press Releases
Scientific Publications/Research
About Little Rock & Arkansas
About UAMS
About The Winthrop P. Rockefeller Cancer Institute
Travel, Hotels, Directions & Maps, UAMS Dining
Other Sources of Myeloma Information
Contact Us
Make a Donation

Job Opportunities

Clinical Faculty

Elias Anaissie, M.D., Professor of Medicine
Vice Chair and Director of Supportive Care, Myeloma Institute

M.D.  University of Paris XII, Creteil Faculty of Medicine, Paris, France,
and St Joseph University Medical School, Beirut, Lebanon. 
Residency (internal medicine), American University of Beirut Medical Center. 
Fellowship (hematology/oncology), American University of Beirut Medical Center. 
Fellowship (infectious diseases), University of Texas M.D. Anderson Cancer Center. 
Associate Professor of Medicine, M.D. Anderson Cancer Center, Houston, Texas. 
Adjunct Associate Professor of Pathology at University of Texas Medical Branch at Galveston.
Special Interest:
Prevention and management of the complications of chemotherapy and stem cell transplantation

Selected Publications:

Talamo G, Angtuaco E, Walker RC, Dong L, Miceli MH, Zangari M, Tricot G, Barlogie B, Anaissie EJ. Avascular necrosis of femoral and/or humeral heads in multiple myeloma: results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapy. J of Clin Onc. 23(22):5217-23, 2005

Sherman AC, Plante TG, Simonton S, Latif U, Anaissie EJ. Prospective study of religious coping among patients undergoing autologous stem cell transplantation.J Behav Med. 2008 Oct 15. [Epub ahead of print]

Miceli MH, Grazziutti ML, Woods G, Zhao W, Kocoglu MH, Barlogie B, Anaissie EJ. Strong Correlation between Serum Aspergillus Galactomannan and Aspergillosis Outcome in Patients with Hematological Cancer: Clinical and Research Implications. Clin Infect Dis. 2008 May 1;46(9):1412-22

Maertens J, Buvé K, Anaissie E. Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: counterpoint. J Natl Compr Canc Netw. 2008 Feb;6(2):183-9

Woods G, Miceli MH, Grazziutti ML, Zhao W, Barlogie B, Anaissie EJ. Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer. Cancer. 2007 Aug 15;110(4):830-4.

Miceli MH, Maertens J, Buve K, Grazziutti M, Woods G, Rahman M, Barlogie B, Anaissie EJ. Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications. Cancer. 2007 Jul 1;110(1):112-20

Grazziutti ML, Dong L, Miceli MH, Krishna SG, Kiwan E, Syed N, Fassas A, van Rhee F, Klaus H, Barlogie B, Anaissie EJ.  Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model.  Bone Marrow Transplant. 2006 Oct;38(7):501-6

Barlogie B, Anaissie E, van Rhee F, Pineda-Roman M, Zangari M, Shaughnessy J, Epstein J, Crowley J.The Arkansas approach to therapy of patients with multiple myeloma. Best Pract Res Clin Haematol. 2007 Dec;20(4):761-81

 

About Multiple Myeloma // About the Myeloma Institute // Becoming a Patient
Highlights of Our Myeloma Program  // Our Physician Team // Our Nursing Team
News/Events/Press Releases // Scientific Publications/Research
About Little Rock & Arkansas // About UAMS // About The Winthrop P. Rockefeller Cancer Institute
Travel/Directions/Maps // Contact Us // Make a Donation

Having problems with the site? E-mail the Webmaster.
Copyright 2002-2005, Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences
Terms and Conditions of Use

The information on the Myeloma Institute web site is not intended as a substitute for professional medical attention. The information is intended only as an aid in understanding current medical knowledge. A physician should always be consulted for any health concern or medical condition. The Myeloma Institute web site provides links to other organizations as a service to our readers. The Myeloma Institute is not responsible for the information provided on other web sites.

Notice of Privacy Practices
Myeloma Institute for Research and Therapy University of Arkansas for Medical Sciences